Trial Profile
A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 05 Sep 2006 Status change
- 17 Aug 2005 New trial record.